Indomethacin activates peroxisome proliferator-activated receptor γ to improve insulin resistance in cotton pellet granuloma model

Hormone and Metabolic Research

Volumn 42, Issue 11, 2010, Pages 775-780

  Wu, H T ^a   Chen, W ^b   Cheng, K C ^c   Yeh, C H ^d   Shen, K H ^e   Cheng, J T ^a,d,e  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^e CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

cotton pellet granuloma; diabetes; indomethacin; insulin resistance; nitric oxide; peroxisome proliferator activated receptor ; prostaglandin E2

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CYCLOOXYGENASE 2; GLUCOSE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRATE; NITRITE; PROSTAGLANDIN E2; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EPIDIDYMIS; GLUCOSE UTILIZATION; GRANULOMA; HOMEOSTASIS; IMMUNOCOMPETENT CELL; INSULIN RESISTANCE; LEUKOCYTE; LEUKOCYTE COUNT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; CELL MOVEMENT; COTTON FIBER; CYCLOOXYGENASE 2; DINOPROSTONE; DISEASE MODELS, ANIMAL; EPIDIDYMIS; GOSSYPIUM; GRANULOMA; INDOMETHACIN; INSULIN RESISTANCE; LEUKOCYTE COUNT; MALE; MICE; MICE, INBRED BALB C; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN;

GOSSYPIUM HIRSUTUM; MUS;

EID: 77957595042     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1261952     Document Type: Article

References (32)

1. Schmidt MI, Duncan BB. Diabesity: an inflammatory metabolic condition. Clin Chem Lab Med 2003 41 1120-1130
2. Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T. Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J 2009 276 5747-5754
3. Andersen K, Pedersen BK. The role of inflammation in vascular insulin resistance with focus on IL-6. Horm Metab Res 2008 40 635-639
4. Mercader J, Granados N, Caimari A, Oliver P, Bonet ML, Palou A. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models. Horm Metab Res 2008 40 467-472
5. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006 116 1793-1801
6. Nieto-Vazquez I, Fernandez-Veledo S, Kramer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem 2008 114 183-194
7. Tremblay F, Jacques H, Marette A. Modulation of insulin action by dietary proteins and amino acids: role of the mammalian target of rapamycin nutrient sensing pathway. Curr Opin Clin Nutr Metab Care 2005 8 457-462
8. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003 112 1785-1788
9. Wu HT, Chang CK, Tsao CW, Wen YJ, Ling SM, Cheng KC, Chang CJ, Cheng JT. Insulin resistance without obesity induced by cotton pellet granuloma in mice. Lab Invest 2009 89 362-369
10. Bolduc C, Larose M, Lafond N, Yoshioka M, Rodrigue MA, Morissette J, Labrie C, Raymond V, St-Amand J. Adipose tissue transcriptome by serial analysis of gene expression. Obes Res 2004 12 750-757
11. Konheim YL, Wolford JK. Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians. Hum Genet 2003 113 377-381
12. Helmersson J, Vessby B, Larsson A, Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 2004 109 1729-1734
13. Hsieh PS, Jin JS, Chiang CF, Chan PC, Chen CH, Shih KC. COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. Obesity (Silver Spring) 2009 17 1150-1157
14. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 2005 289 H2144-H2152
15. Nunes SF, Figueiredo IV, Soares PJ, Costa NE, Lopes MC, Caramona MM. Semicarbazide-sensitive amine oxidase activity and total nitrite and nitrate concentrations in serum: novel biochemical markers for type 2 diabetes? Acta Diabetol 2009 46 135-140
16. FitzGerald GA, Loll P. COX in a crystal ball: current status and future promise of prostaglandin research. J Clin Invest 2001 107 1335-1337
17. Ribeiro M, Cella M, Farina M, Franchi A. Effects of aminoguanidine and cyclooxygenase inhibitors on nitric oxide and prostaglandin production, and nitric oxide synthase and cyclooxygenase expression induced by lipopolysaccharide in the estrogenized rat uterus. Neuroimmunomodulation 2004 11 191-198
18. Maeda T, Kiguchi N, Kobayashi Y, Ozaki M, Kishioka S. Pioglitazone attenuates tactile allodynia and thermal hyperalgesia in mice subjected to peripheral nerve injury. J Pharmacol Sci 2008 108 341-347
19. Plomgaard P, Nielsen AR, Fischer CP, Mortensen OH, Broholm C, Penkowa M, Krogh-Madsen R, Erikstrup C, Lindegaard B, Petersen AM, Taudorf S, Pedersen BK. Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes. Diabetologia 2007 50 2562-2571
20. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 2002 109 1321-1326
21. El Midaoui A, Wu R, de Champlain J. Prevention of hypertension, hyperglycemia and vascular oxidative stress by aspirin treatment in chronically glucose-fed rats. J Hypertens 2002 20 1407-1412
22. Perucca E. Drug interactions with nimesulide. Drugs 1993 46 79-82
23. Kaneki M, Shimizu N, Yamada D, Chang K. Nitrosative stress and pathogenesis of insulin resistance. Antioxid Redox Signal 2007 9 319-329
24. Carvalho-Filho MA, Ropelle ER, Pauli RJ, Cintra DE, Tsukumo DM, Silveira LR, Curi R, Carvalheira JB, Velloso LA, Saad MJ. Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of IRbeta/IRS-1 and Akt. Diabetologia 2009 52 2425-2434
25. Straus DS, Glass CK. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 2007 28 551-558
26. Vasudevan AR, Balasubramanyam A. Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability. Diabetes Technol Ther 2004 6 850-863
27. Hazra S, Dubinett SM. Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells. Prostaglandins Leukot Essent Fatty Acids 2007 77 51-58
28. Xing B, Xin T, Hunter RL, Bing G. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt. J Neuroinflammation 2008 5 4
29. Zhang F, Liu F, Yan M, Ji H, Hu L, Li X, Qian J, He X, Zhang L, Shen A, Cheng C. Peroxisome proliferator-activated receptor-gamma agonists suppress iNOS expression induced by LPS in rat primary Schwann cells. J Neuroimmunol 2010 218 36-47
30. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1997 272 3406-3410
31. Bjorkman DJ. Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury. Am J Med 1996 101 25S-32S
32. Zhang J, Wang J, Wu H, He Y, Zhu G, Cui X, Tang L. Design, synthesis and insulin-sensitizing activity of indomethacin and diclofenac derivatives. Bioorg Med Chem Lett 2009 19 3324-3327